Literature DB >> 3607647

Long-term bone marrow culture systems: normal and cyclic hematopoietic dogs.

Z S Al-Lebban, R D Lange, J B Jones, C D Lothrop.   

Abstract

A continuous long-term liquid culture in both a micro and macro system that incorporates bone marrow cells from normal and cyclic hematopoietic dogs is described. An adherent layer composed of fibroblasts, endothelial cells, mononuclear phagocytic cells, and fat-containing cells is essential for continuous hematopoiesis. Hematopoiesis was measured by the recovery of the nonadherent cells and the generation of committed granulocyte-monocyte progenitor cells for a period of seven weeks. Optimum growth factors include the use of horse serum, fetal bovine serum, dog serum, hydrocortisone, a 33 degrees C incubation temperature and feeding twice a week. As is true for both human and murine marrow liquid cultures, horse serum and hydrocortisone are essential for development and maintenance of fat-containing cells in the described systems. Both factors are important in hematopoiesis but their respective roles have not been defined. Normal and cyclic hematopoietic dogs bone marrow cells are comparable in their ability to establish long-term cultures. The micro-method (Linbro-well culture) gave similar results in maintaining hematopoiesis as did a macromethod (flask culture).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607647      PMCID: PMC1255296     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  26 in total

1.  Cyclic hematopoiesis in a colony of dogs.

Authors:  J B Jones; R D Lange; E S Jones
Journal:  J Am Vet Med Assoc       Date:  1975-02-15       Impact factor: 1.936

2.  Proliferation of haemopoietic stem cells in vitro.

Authors:  T M Dexter; L G Lajtha
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

3.  Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.

Authors:  N N Iscove; F Sieber; K H Winterhalter
Journal:  J Cell Physiol       Date:  1974-04       Impact factor: 6.384

4.  Cyclic hematopoiesis in grey collie dogs: a stem-cell problem.

Authors:  H M Patt; J E Lund; M A Maloney
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

Review 5.  Marrow adipose cells and hemopoiesis: an interpretative review.

Authors:  M Tavassoli
Journal:  Exp Hematol       Date:  1984-02       Impact factor: 3.084

6.  A micromethod for long-term in vitro culture of bone marrow cells.

Authors:  D A Lipschitz; D H Robinson; K B Udupa
Journal:  Exp Hematol       Date:  1984-06       Impact factor: 3.084

7.  Cyclic neutropenia in grey collie dogs.

Authors:  J E Lund; G A Padgett; R L Ott
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

8.  Canine cyclic haematopoiesis: marrow transplantation between littermates.

Authors:  J B Jones; T J Yang; J B Dale; R D Lange
Journal:  Br J Haematol       Date:  1975-06       Impact factor: 6.998

9.  Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs.

Authors:  D C Dale; D W Alling; S M Wolff
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

10.  Canine cyclic neutropenia. A stem cell defect.

Authors:  P L Weiden; B Robinett; T C Graham; J Adamson; R Storb
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more
  2 in total

Review 1.  Regulation of the hematopoietic stem cell lifecycle by the endothelial niche.

Authors:  Pradeep Ramalingam; Michael G Poulos; Jason M Butler
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

Review 2.  Exogenous endothelial cells as accelerators of hematopoietic reconstitution.

Authors:  J Christopher Mizer; Thomas E Ichim; Doru T Alexandrescu; Constantin A Dasanu; Famela Ramos; Andrew Turner; Erik J Woods; Vladimir Bogin; Michael P Murphy; David Koos; Amit N Patel
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.